Vendor profile Research · US · —

Kerui Peptide HongKong

B+
Composite 7.8 / 10

Last updated 2026-09-28. Composite is computed from the live database; missing sub-scores redistribute weight across the others.

Lab quality
7.5
Good
Sentiment
—
—
COA
—
Limited
Reliability
—
— tenure
Pricing
10.0
Verified

Peptide breakdown

PeptideScoreLab qualityTestsPurity Qty var.$/mg verifiedLast testRanking
Tirzepatide
8.3B+
7.9 5 — — — — view
Retatrutide
7.7B+
7.1 14 — — — — view
Tesamorelin
—
— 1 — — — — view
Sermorelin
—
— 0 — — — — view
MOTS-c
—
— 0 — — — — view
KPV
—
— 0 — — — — view
Ipamorelin
—
— 0 — — — — view
GHK-Cu
—
— 0 — — — — view
Epitalon
—
— 0 — — — — view
CJC-1295
—
— 0 — — — — view
BPC-157
—
— 0 — — — — view

COA transparency

  • ○ Publishes per-batch COAs (not just one COA for everyone) (pending)
  • ○ Both HPLC and mass spec shown (pending)
  • ○ Endotoxin or sterility data shown (pending)
  • ○ At least one COA independently cross-checked (pending)
  • ○ Most recent COA within 90 days (pending)
All vendor grades, side-by-side
Compare Kerui Peptide HongKong against every other vendor in the grade hub →
Top-5 ranked vendors per peptide, plus the highest-rated vendors overall. Daily refresh.